FY 2016-17 year was another exceptional one for fast-growing global private equity investment.
Capital committed to traditional funds, co-investments, separate accounts and direct deals
hit an all-time annual record of $681 billion, beating the previous high set in 2015 by 9
percent. Private equity looks set for further records this FY 2017-18 as new investors
enter the asset category and as veterans continue to increase relative allocations.
Investor’s main focus is the high growth region of ‘Pharmaceuticals’, FMCG, Service and
Health Care verticals. New Investors with major PE firms in last year are: Tybourne Capital,
Steadview Capital, Brookfield
Asset Management Inc., Baillie Gifford and Co., PSP Investments, and Greenoaks Ventures.
We help clients for developing the base documents to be prepared and presented
to the PE analysts and organize meetings with the potential investors.
COMPAXED team helps for the following tasks in PE / VC:
- Fund disbursal application and compliances till the agreed period
- Deal Finalization
- Technical and Commercial Due Diligence
- Legal frame work and agreement signing
- Risk assessments
- Comparative Analytics for the similar segment entry and exit options
- Portfolio Management
